相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel therapeutic options for multiple sclerosis
Francois Curtin et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Oligodendrocyte Progenitor Cell Susceptibility to Injury in Multiple Sclerosis
Qiao-Ling Cui et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Human Endogenous Retrovirus Type W Envelope Protein Inhibits Oligodendroglial Precursor Cell Differentiation
David Kremer et al.
ANNALS OF NEUROLOGY (2013)
Dabigatran: Is There a Role for Coagulation Assays in Guiding Therapy?
Luigi Brunetti et al.
ANNALS OF PHARMACOTHERAPY (2013)
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Aran Groves et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Treatment trials in progressive MS-current challenges and future directions
Marcus W. Koch et al.
NATURE REVIEWS NEUROLOGY (2013)
The structure and function of the S1P1 receptor
Catherine O'Sullivan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2012)
The Complex World of Oligodendroglial Differentiation Inhibitors
David Kremer et al.
ANNALS OF NEUROLOGY (2011)
Fingolimod is a potential novel therapy for multiple sclerosis
Orhan Aktas et al.
NATURE REVIEWS NEUROLOGY (2010)
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
Orhan Aktas et al.
TRENDS IN NEUROSCIENCES (2010)
分享论文
